NOT FOR DISTRIBUTION
Header cover image

Market Cap

€486.1m

Last Updated

2021/05/18 01:40 UTC

Data Sources

Company Financials +

Executive Summary

LNA Santé SA operates and manages full-care facilities for the dependent elderly persons under the LNA Santé brand in France and Belgium. More Details


Snowflake Analysis

Reasonable growth potential and slightly overvalued.


Similar Companies

Share Price & News

How has LNA Santé's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine LNAP's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine LNAP's volatility change over the past year.


Market Performance


7 Day Return

0%

LNAP

4.4%

GB Healthcare

0.2%

GB Market


1 Year Return

12.3%

LNAP

50.5%

GB Healthcare

22.8%

GB Market

Return vs Industry: LNAP underperformed the UK Healthcare industry which returned 50.5% over the past year.

Return vs Market: LNAP underperformed the UK Market which returned 22.8% over the past year.


Shareholder returns

LNAPIndustryMarket
7 Day0%4.4%0.2%
30 Day0%5.7%0.1%
90 Day-2.2%14.6%5.1%
1 Year13.4%12.3%52.6%50.5%28.3%22.8%
3 Year-10.0%-12.1%-10.0%-14.4%9.4%-3.1%
5 Year56.7%51.5%-15.1%-21.1%47.0%19.3%

Long-Term Price Volatility Vs. Market

How volatile is LNA Santé's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is LNA Santé undervalued compared to its fair value and its price relative to the market?

42.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: LNAP (€45.95) is trading below our estimate of fair value (€79.19)

Significantly Below Fair Value: LNAP is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: LNAP is poor value based on its PE Ratio (62.4x) compared to the UK Healthcare industry average (40.9x).

PE vs Market: LNAP is poor value based on its PE Ratio (62.4x) compared to the UK market (25.6x).


Price to Earnings Growth Ratio

PEG Ratio: LNAP is poor value based on its PEG Ratio (1.7x)


Price to Book Ratio

PB vs Industry: LNAP is overvalued based on its PB Ratio (2.6x) compared to the GB Healthcare industry average (2.1x).


Future Growth

How is LNA Santé forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

37.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: LNAP's forecast earnings growth (37.2% per year) is above the savings rate (0.9%).

Earnings vs Market: LNAP's earnings (37.2% per year) are forecast to grow faster than the UK market (17.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LNAP's revenue (9.4% per year) is forecast to grow faster than the UK market (5.3% per year).

High Growth Revenue: LNAP's revenue (9.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LNAP's Return on Equity is forecast to be low in 3 years time (14.4%).


Past Performance

How has LNA Santé performed over the past 5 years?

-2.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: LNAP has a large one-off loss of €7.3M impacting its December 31 2020 financial results.

Growing Profit Margin: LNAP's current net profit margins (1.4%) are lower than last year (3.9%).


Past Earnings Growth Analysis

Earnings Trend: LNAP's earnings have declined by 2.3% per year over the past 5 years.

Accelerating Growth: LNAP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: LNAP had negative earnings growth (-62.4%) over the past year, making it difficult to compare to the Healthcare industry average (1.3%).


Return on Equity

High ROE: LNAP's Return on Equity (4.3%) is considered low.


Financial Health

How is LNA Santé's financial position?


Financial Position Analysis

Short Term Liabilities: LNAP's short term assets (€306.0M) do not cover its short term liabilities (€561.9M).

Long Term Liabilities: LNAP's short term assets (€306.0M) do not cover its long term liabilities (€739.3M).


Debt to Equity History and Analysis

Debt Level: LNAP's debt to equity ratio (230.8%) is considered high.

Reducing Debt: LNAP's debt to equity ratio has reduced from 240% to 230.8% over the past 5 years.

Debt Coverage: LNAP's debt is well covered by operating cash flow (32.4%).

Interest Coverage: LNAP's interest payments on its debt are not well covered by EBIT (2.2x coverage).


Balance Sheet


Dividend

What is LNA Santé current dividend yield, its reliability and sustainability?

0.39%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: LNAP's dividend (0.39%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.39%).

High Dividend: LNAP's dividend (0.39%) is low compared to the top 25% of dividend payers in the UK market (4.12%).


Stability and Growth of Payments

Stable Dividend: LNAP is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.

Growing Dividend: LNAP is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: LNAP is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LNAP's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.9yrs

Average board tenure


CEO

Jean Siret (69 yo)

28.83yrs

Tenure

€324,000

Compensation

Mr. Jean paul siret has been the Chairman and Chief Executive Officer of le noble-age., since july 30, 1992. He also serves as Founder of LNA Santé SA. Mr. Siret served as the chief executive officer of sa...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Jean's total compensation is reasonable compared to companies of similar size in the UK market.

Compensation vs Earnings: Jean's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: LNAP's board of directors are considered experienced (7.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

LNA Santé SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: LNA Santé SA
  • Ticker: LNAP
  • Exchange: BATS-CHIXE
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €486.109m
  • Shares outstanding: 9.57m
  • Website: https://www.lna-sante.com

Number of Employees


Location

  • LNA Santé SA
  • 7 Boulevard Auguste Priou
  • PO Box 32336
  • Vertou
  • Pays de la Loire
  • 44120
  • France

Listings


Biography

LNA Santé SA operates and manages full-care facilities for the dependent elderly persons under the LNA Santé brand in France and Belgium. The company operates nursing homes, follow-up care and rehabilitati...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/18 01:40
End of Day Share Price2021/02/24 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.